CAH - Cardinal Health, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $2.78
|
Rev Est: $62.2B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$248.44
DETAILS
HIGH:
$260.00
LOW:
$220.00
MEDIAN:
$255.00
CONSENSUS:
$248.44
UPSIDE:
9.94%
Market Cap:
53.17B
Volume:
1,434,775
Avg Volume:
1,900,981
52 Week Range:
120.72-230.81
Sector:
Healthcare
Industry:
Medical - Distribution
Beta:
0.66
Last Dividend:
$2.04
Exchange:
NYSE
Country:
US
Employees:
47,922
IPO Date:
1983-08-04
EPS (TTM):
6.48
P/E Ratio:
25.94
Revenue (TTM):
222.58B
Total Assets:
53.12B
Total Debt:
9.35B
Cash & Equiv:
3.87B
Rev Growth (5Y):
7.8%
EPS Growth (5Y):
4.5%
FCF Growth (5Y):
3.1%
ROCE:
16.3%
Debt/Equity:
-3.36
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $2.63 | $2.34 | +12.4% | $65.4B | $65.1B | +0.6% |
| 2025-10-30 | $2.55 | $2.18 | +17.0% | $64.0B | $59.2B | +8.1% |
| 2025-08-12 | $2.08 | $2.04 | +2.0% | $60.2B | $60.9B | -1.2% |
| 2025-05-01 | $2.35 | $2.17 | +8.3% | $54.9B | $55.4B | -0.9% |
| 2025-01-30 | $1.93 | $1.74 | +10.9% | $55.3B | $55.0B | +0.4% |
| 2024-11-01 | $1.88 | $1.62 | +16.0% | $52.3B | $50.9B | +2.7% |
| 2024-08-14 | $1.84 | $1.73 | +6.4% | $59.9B | $58.6B | +2.1% |
| 2024-05-02 | $2.08 | $1.95 | +6.7% | $54.9B | $56.1B | -2.0% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 222.58B | 226.83B | 204.98B | 181.33B | 162.47B | 152.92B | 145.53B | 136.81B | 129.98B | 121.55B | 102.53B | 91.08B |
| Net Income | 1.56B | 852.00M | 330.00M | (938.00M) | 611.00M | (3.69B) | 1.36B | 256.00M | 1.29B | 1.43B | 1.22B | 1.17B |
| EPS | 6.48 | 3.48 | 1.26 | -3.34 | 2.09 | -12.60 | 4.54 | 0.82 | 4.06 | 4.36 | 3.66 | 3.42 |
| Total Assets | 53.12B | 45.12B | 43.35B | 43.88B | 44.45B | 40.77B | 40.96B | 39.95B | 40.11B | 34.12B | 30.14B | 26.03B |
| Total Debt | 9.35B | 5.61B | 5.18B | 5.80B | 6.71B | 6.78B | 8.03B | 9.01B | 10.39B | 5.54B | 5.49B | 3.97B |
| Cash & Equivalents | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B | 2.77B | 2.53B | 1.76B | 6.88B | 2.36B | 4.62B | 2.87B |
| Operating Cash Flow | 2.40B | 3.76B | 2.84B | 3.12B | 2.43B | 1.96B | 2.72B | 2.77B | 1.18B | 2.97B | 2.54B | 2.52B |
| Free Cash Flow | 1.85B | 3.25B | 2.36B | 2.73B | 2.03B | 1.58B | 2.39B | 2.38B | 797.00M | 2.51B | 2.24B | 2.27B |
| FCF per Share | 7.68 | 13.27 | 9.05 | 9.80 | 6.95 | 5.41 | 7.98 | 7.62 | 2.51 | 7.66 | 6.75 | 6.67 |
| Book Value | (2.78B) | (3.21B) | (2.96B) | (709.00M) | 1.79B | 1.79B | 6.33B | 6.06B | 6.81B | 6.55B | 6.26B | 6.40B |
| Cash & ST Investments | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B | 2.77B | 2.53B | 1.76B | 6.88B | 2.36B | 4.62B | 2.87B |
| ROC Equity | N/A | N/A | N/A | N/A | 0.34 | -2.06 | 0.22 | 0.04 | 0.19 | 0.22 | 0.19 | 0.18 |